ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 740253 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 740253; 2) Community: the network communities that were significantly associated with the response to NSC 740253; 3) Molecule: the relationships between components within communities and NSC 740253; 4) MDR: the compounds that were significantly associated with the NSC 740253.

NSC Compound Enrichment Correlation
NSC 672140 Null 0.000120353817593339 0.413233
NSC 718781 Erlotinib hydrochloride 0.000120353817593339 -0.16208288
NSC 726217 Combretastatin A4-analogue 0.000120353817593339 0.56369484
NSC 755264 Null 0.000180534163860495 0.38425162
NSC 755267 Null 0.000180534163860495 0.36399755
NSC 760016 (E)-3-(3,5-dimethoxyphenyl)-1-(4-(quinazolin-4-ylamino)phenyl)prop-2-en-1-one 0.000180534163860495 0.33428911
NSC 105023 RUBIFLAVIN 0.000240704629800692 0.33945537
NSC 208652 2,4-Quinazolinediamine, 5-chloro-6-[[(3,4-dichlorophenyl)amino]methyl]- 0.000240704629800692 0.31109653
NSC 225112 2,4,6-Quinazolinetriamine, N(6)-[(3,4-dichlorophenyl)methyl]-N(6)-ethyl-5-methyl- 0.000240704629800692 0.34493959
NSC 3082 s-Triazine, 4,6-diamino-1-(m-bromophenyl)-1,2-dihydro-2,2-dimethyl-, hydrochloride (8CI) 0.000240704629800692 0.38080972
Total:101  Current:1    [First] [Prev] [Next] [Last]